Balloon Ostial Dilation Of The Frontal And Sphenoid Sinuses denials: what the review data shows
Independent reviewers have decided 16 published cases where an insurer denied Balloon Ostial Dilation Of The Frontal And Sphenoid Sinuses — and they overturned the insurer 100% of the time. A denial for Balloon Ostial Dilation Of The Frontal And Sphenoid Sinuses is a starting position, not a final answer.
By condition
| Condition | Decisions | Overturned |
|---|---|---|
| Chronic Rhinosinusitis | 16 | 100% |
Where the denial was overturned
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for balloon ostial dilation of the maxillary sinus x 2, balloon ostial dilation of the frontal and sphenoid sinuses x 2, nasal/sinus endoscopy, surgical with ethmoidectomy x 2. Balloon dilation of the sinuses (BDS) is typically performed for the treatment of either recurrent acute (RARS) or chronic rhinosinusitis (CRS). The ostiomeatal complex (OMC) is a particularly important concept in functional endoscopic sinus surgery (FESS). It represents the common drainage pathway for the frontal sinus, anterior ethmoid air cells, and maxillary sinus into the middle meatus. Surgical correction of OMC obstruction requires both the widening of the maxillary sinus ostium and the taking down of the anterior ethmoid air cells.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for balloon ostial dilation procedure of the bilateral frontal and sphenoid sinuses. Balloon sinus dilation is typically performed for either recurrent acute rhinosinusitis (RARS) or chronic rhinosinusitis (CRS). Balloon sinus dilation offers a significant benefit over traditional functional endoscopic sinus surgery (FESS) as it carries less morbidity and can frequently be accomplished in an office setting. Balloon sinus dilation should only be recommended to patients who meet the strict diagnostic criteria for rhinosinusitis and who are refractory to maximal medical management.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Balloon Ostial Dilation Of The Frontal And Sphenoid Sinuseswhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY